|
|
Article: Court Confirms PharmaNetics' Allegation That Aventis Has Engaged in False Advertising of Lovenox; PharmaNetics Entitled to Jury Trial.
- Article from:
- Business Wire
- Article date:
- May 4, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
RALEIGH, N.C.--(BUSINESS WIRE)--May 4, 2004
PharmaNetics, Inc. (NASDAQ-SmallCap: PHAR) today announced that it has received a ruling from the United States District Court of the Eastern District of North Carolina.
In November 2003, PharmaNetics, Inc. filed a lawsuit in the United States District Court of the Eastern District of North Carolina against Aventis Pharmaceuticals, Inc., the wholly owned subsidiary of French pharmaceutical company, Aventis. The lawsuit alleges that Aventis has engaged in false and misleading advertising of its second largest drug, Lovenox(R). In addition to claims of false ...